PHARMEXCIL To Showcase India’s Pharma Excellence At Arab Health

The Pharmaceutical Export Promotion Council of India (PHARMEXCIL) has reaffirmed its commitment to strengthening the partnership between India and the United Arab Emirates (UAE) in the pharmaceutical sector. On January 23, 2025, Raja Bhanu, Director General of PHARMEXCIL, and AVPS Chakravarthi, Honorary Advisor, met with Aref Ali Alnuaimi, the UAE Consul General, in Hyderabad. Their discussion focused on the two countries' strong economic and trade relationship, emphasising collaboration in pharmaceutical exports, drug development, vaccines, formulations, and Active Pharmaceutical Ingredients (APIs).

Mr.Raja Bhanu, Director General of PHARMEXCIL, stated, “India and the UAE share a deep-rooted partnership that has grown into a robust strategic collaboration. PHARMEXCIL is honoured to contribute to this partnership by fostering deeper engagement in the pharmaceutical sector. Arab Health 2025 provides an excellent platform to demonstrate India’s capabilities and explore mutually beneficial opportunities in the UAE and beyond.”

As part of these efforts, PHARMEXCIL will organise the India Pavilion at Arab Health 2025, a leading healthcare and pharmaceutical exhibition. The event will occur from January 27-30, 2025, at the World Trade Center in Dubai and will be inaugurated by Satish Kumar Siven, India’s Consul General to the UAE. The India Pavilion will feature 65 top Indian pharmaceutical companies, showcasing India’s pharmaceutical manufacturing and innovation expertise. It will allow Indian businesses to connect with global stakeholders, explore new markets, and strengthen ties with the UAE’s healthcare sector.